Substance Name: Ixmyelocel-T
- Manufacturers Statement: Ixmyelocel-T is a patient-specific, expanded multicellular therapy, manufactured using Vericels proprietary, highly automated, fully closed cell-processing system. Vericels patent-protected technology selectively expands mesenchymal cells, monocytes and alternatively activated macrophages, up to several hundred times more than the number found in the patients bone marrow, while retaining many of the hematopoietic cells collected from only a small sample (50ml) of the patients bone marrow.
* denotes mobile formatted website
Links to Resources
Names and Synonyms
- Cardiac Repair Cell (CRC) Treatment
- Tissue Repair Cells (TRC)